Altogether, these human clinical data align well with our conclusion derived from the DMBA/TPA-induced tumor study (Fig. 3), in which an Nf1+/− microenvironment played an antagonistic role throughout the stepwise cancer progression. The gene discussed is NF1; the disease is cancer.